BREAKING
Key metrics from Lowe’s (LOW) Q4 2025 earnings results 4 hours ago Earnings Preview: Best Buy (BBY) expected to report lower earnings in Q4 2026 21 hours ago Apple Inc. (AAPL) Surges 5.1% — Developing Story 23 hours ago Mastercard Incorporated (MA) Drops 5.6% — Developing Story 23 hours ago UnitedHealth Group Incorporated (UNH) Drops 5.8% — Developing Story 23 hours ago Accenture plc (ACN) Drops 6.0% — Developing Story 23 hours ago International Business Machines Corporation (IBM) Drops 9.4% — Developing Story 23 hours ago Salesforce, Inc. (CRM) Surges 5.4% — Developing Story 23 hours ago Advanced Micro Devices, Inc. (AMD) Surges 8.5% — Developing Story 23 hours ago Salesforce, Inc. (CRM) Surges 5.4% — Developing Story 1 day ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 4 hours ago Earnings Preview: Best Buy (BBY) expected to report lower earnings in Q4 2026 21 hours ago Apple Inc. (AAPL) Surges 5.1% — Developing Story 23 hours ago Mastercard Incorporated (MA) Drops 5.6% — Developing Story 23 hours ago UnitedHealth Group Incorporated (UNH) Drops 5.8% — Developing Story 23 hours ago Accenture plc (ACN) Drops 6.0% — Developing Story 23 hours ago International Business Machines Corporation (IBM) Drops 9.4% — Developing Story 23 hours ago Salesforce, Inc. (CRM) Surges 5.4% — Developing Story 23 hours ago Advanced Micro Devices, Inc. (AMD) Surges 8.5% — Developing Story 23 hours ago Salesforce, Inc. (CRM) Surges 5.4% — Developing Story 1 day ago
ADVERTISEMENT
AlphaGraphs

Pfizer (PFE) Q2 2024 Earnings: Key financials and quarterly highlights

Pfizer Inc. (NYSE: PFE) reported its second quarter 2024 earnings results today. Revenues increased 2% year-over-year to $13.3 billion. Revenues grew 3% operationally. Reported net income fell 98% to $41 million, or $0.01 per share, compared to last year. Adjusted EPS dropped 11% to $0.60. For the full year of 2024, Pfizer expects revenues of […]

$PFE July 30, 2024 1 min read

Pfizer Inc. (NYSE: PFE) reported its second quarter 2024 earnings results today.

Revenues increased 2% year-over-year to $13.3 billion. Revenues grew 3% operationally.

Reported net income fell 98% to $41 million, or $0.01 per share, compared to last year. Adjusted EPS dropped 11% to $0.60.

For the full year of 2024, Pfizer expects revenues of $59.5-62.5 billion. Adjusted EPS is expected to be $2.45-2.65.

Prior performance

ADVERTISEMENT